Copenhagen - Free Realtime Quote DKK
Orphazyme A/S (ORPHA.CO)
As of 12:55 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2021
12/31/2020
12/31/2019
Total Revenue
36,193.00
36,193.00
--
--
Operating Expense
639,448.00
669,496.00
608,534.00
335,954.00
Operating Income
-603,255.00
-633,303.00
-608,534.00
-335,954.00
Net Non Operating Interest Income Expense
-9,537.00
-9,568.00
-14,221.00
-4,566.00
Other Income Expense
--
11,391.00
-12,406.00
-2,477.00
Pretax Income
-601,400.00
-631,480.00
-635,161.00
-342,997.00
Tax Provision
-5,416.00
-4,941.00
-1,915.00
-5,500.00
Net Income Common Stockholders
-99,776.00
-626,539.00
-633,246.00
-337,497.00
Diluted NI Available to Com Stockholders
-99,776.00
-626,539.00
-633,246.00
-337,497.00
Basic EPS
-2.88k
-17.94k
-22.32k
-16.85k
Diluted EPS
-2.88k
-17.94k
-22.32k
-16.85k
Basic Average Shares
35.10
34.92
28.37
20.02
Diluted Average Shares
35.31
34.92
28.37
20.02
Total Operating Income as Reported
--
-633,303.00
-608,534.00
-335,954.00
Total Expenses
639,448.00
669,496.00
608,534.00
335,954.00
Net Income from Continuing & Discontinued Operation
-99,776.00
-626,539.00
-633,246.00
-337,497.00
Normalized Income
-607,271.42
-637,840.87
-620,877.40
-335,059.72
Interest Income
68.00
37.00
45.00
316.00
Interest Expense
9,458.00
9,458.00
14,114.00
4,803.00
Net Interest Income
-9,537.00
-9,568.00
-14,221.00
-4,566.00
EBIT
-591,942.00
-622,022.00
-621,047.00
-338,194.00
EBITDA
-591,942.00
-603,911.00
-615,847.00
-334,391.00
Reconciled Depreciation
--
18,111.00
5,200.00
3,803.00
Net Income from Continuing Operation Net Minority Interest
-595,983.00
-626,539.00
-633,246.00
-337,497.00
Total Unusual Items Excluding Goodwill
11,391.00
11,391.00
-12,406.00
-2,477.00
Total Unusual Items
11,391.00
11,391.00
-12,406.00
-2,477.00
Normalized EBITDA
-603,333.00
-615,302.00
-603,441.00
-331,914.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
102.58
89.13
-37.40
-39.72
12/31/2019 - 11/21/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
0.8730
-2.57%
9RP.F Lipigon Pharmaceuticals AB (publ)
0.0010
-16.67%
LVCLF Algorae Pharmaceuticals Limited
0.0035
0.00%
LYTIX.OL Lytix Biopharma AS
6.20
+1.64%
ACE.ST Ascelia Pharma AB (publ)
2.2000
-0.23%
FLUI.ST Fluicell AB (publ)
0.0748
+1.63%
XSPRAY.ST Xspray Pharma AB (publ)
62.10
+2.14%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2110
+17.22%
HNSA.ST Hansa Biopharma AB (publ)
41.48
+2.42%
FLUO.ST FluoGuide A/S
37.00
-3.52%